Hypertension
Hypertension vaccine CYT006-AngQb shows reduction in daytime blood pressure
Published in Vaccine Weekly, February 28th, 2007
The study was a double-blind, placebo-controlled clinical trial conducted with 72 participants with mild to moderate hypertension. It was designed to evaluate safety, tolerability, and exploratory efficacy of two dose levels of the vaccine . For efficacy evaluation, the change in blood pressure from baseline to post-treatment was assessed in individual subjects by 24-hour ambulatory blood pressure monitoring.
Treatment with CYT006-AngQb was safe and very well tolerated. The majority of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2007-02-28)
More Articles from Vaccine Weekly
- Allergy & Immunology
Allergy Therapeutics reports positive phase 2 U.S. FDA meeting on Pollinex Quattro Ragweed - DNA Vaccines
Research results from United States Army Medical Research Institute of Infectious Disease update understanding of DNA vaccines - Vaccine Efficacy
Scientists at University of G d'Annunzio target vaccine efficacy - Avian Influenza
BioSante Pharmaceuticals reports positive bird flu results using vaccine adjuvant - Business Update
Cytogenix reviews year - HIV/AIDS Research
First large-scale HIV vaccine trial in South Africa opens - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
